Intermountain Healthcare Utah, The University of Texas Health Science Center at Houston (UTHealth) and Rush University Medical Center have joined physIQ’s DeCODe study to create an artificial intelligence (AI)-based Covid-19 digital biomarker in the US.
In the DeCODe study, funded by the US National Institutes of Health (NIH), these institutions will act as recruiting sites and crucial partners in Phase II validation.
Biomarker development could allow early identification of a quick clinical decompensation in Covid-19 patients who are at increased risk.
